UnitedHealth Group Incorporated (NYSE:UNH) finished Friday with an addition of $1.02 to close at $489.12, an upside of 0.21 percent. An average of 1,971,840 shares of common stock have been traded in the last five days. There was a fall of -$9.32 in the past week, and it reached a new high 5 times over the past 12 months. The last 20 days have seen an average of 2,214,555 shares traded, while the 50-day average volume stands at 3,617,096.
UNH stock has decreased by -3.19% in the last month. The company shares reached their 1-month lowest point of $484.65 on 08/25/23. With the stock rallying to its 52-week high on 04/13/23, shares of the company touched a low of $445.68 and a high of $558.10 in 52 weeks. It has reached a new high 3 times so far this year and lost -7.74% or -$41.06 in price. In spite of this, the price is down -12.36% from the 52-week high.
Insider Transactions
UNH stock investors should be aware that UnitedHealth Group Incorporated (UNH) stock had its last reported insider trading activity 38 days ago on Jul 19. In this transaction, the insider spent $2,024,760. CEO, UHG, WITTY ANDREW, disposed of 6,160 shares at a price of $487.49 on Apr 27. The insider now owns more than $3,002,949 worth of shares. Prior to that, EVP Chief People Officer McSweeney Erin went on to Sale 761 shares at $494.80 each on Apr 25. An amount of $376,543 was transacted.
Valuation Metrics
UnitedHealth Group Incorporated (UNH) has a trailing price-to-earnings (P/E) ratio of 21.88. The stock’s beta is 0.66. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 1.29, the price-to-book (PB) ratio at 5.52, and the price-to-cash flow ratio at 11.76.
Financial Health
Further, the company has a long term debt to equity ratio of 0.72 and a total debt to equity ratio of 0.80 for the quarter ending June 29. Its gross profit as reported stood at $79.62 billion compared to revenue of $324.16 billion.
Earnings Surprise
For the three-month period that ended June 29, UnitedHealth Group Incorporated had $59.27 billion in total debt. In the quarter under review, the net income was up than the previous quarter. The company posted a net income of $5.47 billion in the quarter, while revenues of $5.61 billion were grew 7.38%. The analyst consensus anticipated UnitedHealth Group Incorporated’s latest quarter earnings to come in at $5.99 per share, but it turned out to be $6.14, a 2.50% surprise. For the quarter, EBITDA amounted to $9.08 billion. Shareholders own equity worth $926.3 million.
Technical Picture
From a technical analysis perspective, let’s take a brief look at UnitedHealth Group Incorporated (UNH) price momentum. RSI 9-day as of the close on 25 August was 35.46%, suggesting the stock is Neutral, with historical volatility in this time frame at 11.32%.
As of today, UNH’s price is $491.34 -1.87% or -$9.32 from its 5-day moving average. UNH is currently trading -2.74% lower than its 20-day SMA and -1.03% lower than its 100-day SMA. However, the stock’s current price level is +6.36% above the SMA50 and -10.26% below the SMA200.
The stochastic %K and %D were 8.22% and 8.41%, respectively, and the average true range (ATR) was 7.51. With the 14-day stochastic at 15.41% and the average true range at 7.95, the RSI (14) stands at 42.28%. The stock has reached -6.59 on the 9-day MACD Oscillator while the 14-day reading was at -10.38.
Analyst Ratings
UBS reiterated its a Neutral rating on UnitedHealth Group Incorporated (NYSE: UNH), but raised their price target to $510, indicating a potential price increase of 4.09% for the stock. The consensus rating for UnitedHealth Group Incorporated (UNH) among analysts is Buy. According to current brokerage recommendations, 0 brokerage firms advise that investors sell UNH, while 4 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 3 analysts, while 18 others rate it as a “buy”.
What is UNH’s price target for the next 12 months?
Analysts predict a range of price targets between $520.00 and $650.00, with a median target of $567.50. Taking a look at these predictions, the average price target given by analysts for UnitedHealth Group Incorporated (UNH) stock is $572.75.
